REVH

Revolution Healthcare Acquisition Corp.

SPAC Target Focus: Healthcare & Medical
Expected Close Date: March 17, 2023
IPO Date: 2021-03-17
IPO Size(M): $ 550M
Underwriters: Morgan Stanley

Management

Jeff Leiden (Exec Chairman/Fmr CEO, Vertex Pharmaceuticals; Fmr COO, Abbott Laboratories), Robert Nelsen (Co-founder/Managing Director, ARCH), Jennifer Schneider (Fmr Pres/Chief Medical Officer, Livongo Health), Hemant Taneja (Managing Director, General Catalyst)

Management Team / Advisory Board Bios

Amount Raised : $0

Reveal the Score by Voting

＿

Additional ratings from other users are needed to determine a viable CrowdScore for this deal.

The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.

ⓘ

The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.

Business Idea

ⓘ

The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.

Business Traction

ⓘ

The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.

Management Team

ⓘ

The value of the company compared to similar companies raising money from investors.

Valuation

Have you done enough research to provide a rating? This is important for your fellow investors.

We only allow one revision to each rating category. Be sure about any changes.

Research Reports

No reports have been submitted

Become a Reporter

Read Our Research Disclaimer

0 Comments

To claim your deal, you must have access to @ email

Contact support@crowdlustro.com if you need assistance.